SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Ike Swetlitz
Health
Wegovy, Ozempic shortage declared over, hitting copycats like Hims & Hers
By
Bloomberg
,
Madison Muller
, and others
Health
Demand for weight-loss drug Zepbound is so strong that Eli Lilly is warning patients may leave pharmacies empty-handed
By
Ike Swetlitz
,
Madison Muller
, and others
Health
FDA allows imports of French syphilis drug alternate during US penicillin shortage
By
Ike Swetlitz
and
Bloomberg
Health
Pfizer plant’s tornado damage may exacerbate existing shortages of critical drugs
By
Ike Swetlitz
and
Bloomberg
Health
The ADHD drug shortage is spreading as supplies of a popular alternative to Adderall run worryingly low
By
Ike Swetlitz
and
Bloomberg
Health
Secret limits to stop ‘suspicious’ Xanax and Adderall orders are forcing some legitimate patients to scramble
By
Ike Swetlitz
and
Bloomberg
Leadership
Donald Trump Was Named ‘Grand Benefactor’ For a Charity—Without Giving a Dime
By
Ike Swetlitz
and
STAT News